Rankings Financial data & insurance broking Travelers
Travelers
65
15070100
A view of the same findings, not a new score. How it works
A good business with a real question mark: the price, a crack, or both.
Biggest deductions
- Multiples vs own history−5
- Quality of growth−3
- Price cycle−3
Strengths
- Dividend and buybacks+3
- Underlying operations+2
How the score is built
From 100 to 65, step by step: points off for the business, the price and the cracks, back for documented strengths, then three data adjustments.
Start
Score
Hover or select a step to see what drove it. Steps with findings open them below.
Key numbers
As of 2 Nov 2026. Analyst targets tend to be optimistic; read upside as a hint, not a forecast.
- Price
- 398.80 USD
- Median analyst target
- 379.50 USD
- Upside to median
- −4.8%
- Analysts
- 29
- Target range
- 262.00 – 460.00 USD
- 52-week change
- +48%
- P/E (trailing)
- 10.4
- Forward P/E
- 13.0
- PEG
- 4.41
Findings
Every deduction and every plus, with its source. Open a step to read them.
Business
Is the company getting stronger, not just bigger? · 1 finding−3 of −30
- −3Quality of growthEPS (TTM) of USD 37.34 versus 27.43 in 2025 is driven by low catastrophe losses (USD 518m in Q2 versus 927m) and reserve releases (578m in Q2); premium growth is low (Business Insurance +5% adjusted for Canada). Analysts expect EPS of about USD 34.5, i.e. lower than TTM.
Price
Today's multiples against the company's own history and its peers. · 2 findings−7 of −35
- −5Multiples vs own historyP/B 2.32 versus 1.33-2.04 in 2021-2025 (about 14% above the top of the range); forward P/E 12.1 versus 10.8-13.7 (mid-range). Trailing P/E 9.9 looks cheap, but is calculated on earnings with unusually low catastrophe losses.
- −2PeersP/B 2.32 versus Chubb 1.75 and Allstate 1.84; forward P/E 12.1 is in line with Chubb (12.0) and above Allstate (8.0). The share price is above the analysts' median price target (USD 359.5).
Cracks
Cash flow, customers, debt, insiders, guidance and what sits behind the headline numbers. · 4 findings−8 of −35
- −3Price cycleRenewal premium change in Business Insurance has fallen from 6.1% in Q4 2025 to 5.8% in Q1 and 4.8% in Q2 2026; management itself has mentioned that price increases in some segments are below loss inflation. The market is softening.
- −2Catastrophe lossesEarnings swing wildly with the weather: catastrophe losses of 2.27bn USD in Q1 2025 (including the Los Angeles wildfires) and a Personal Insurance combined ratio of 101.7 in H1 2025 versus 81.2 in H1 2026.
- −2Reserves and earnings qualityFavourable reserve development of 578m USD pre-tax in Q2 (Business Insurance 319m versus 79m a year earlier) carries a large part of the result; reserve releases cannot be repeated indefinitely, and the company has historically taken annual asbestos reserve charges.
- −1
Plus
Only documented strengths. · 2 findings+5 of +15
- +3Dividend and buybacksShare count -4.0% over a year and 20 years of dividend growth (+9.3%); buybacks 1.31bn USD in Q2, and total distribution (approx. 5.4% of market cap, approx. 4.2bn USD) is far below operating cash flow of 11.0bn USD.
- +2Underlying operationsUnderlying combined ratio of 84.1 in Q2 2026; record new business of USD 805m in Business Insurance with retention of 86%, and ROE of 26.5% (ROIC 20.8%) with low debt (debt/EBITDA 0.8).
Caveats
What the score does not capture, or where the data is weak.
Q3 report Friday 16 Oct. 2026 before the open; the score is from before the report, and the Q3 catastrophe losses (hurricane season) are not known. Insurance: FCF and ROIC are not fully comparable; valuation on P/B and P/E. The TTM figures are lifted by low catastrophe losses and large reserve releases, and revenue falls about 11% in 2026 due to the sale of the Canadian operations (closed 2 Jan. 2026). stockanalysis shows only 2021-2025, so the 10-year history has not been examined. The share price is +30% in a year and above the analysts' median price target.
Also in Financial data & insurance broking
The highest scores in the same industry.
